Treatment 2.0
"Treatment 2.0" is a WHO/UNAIDS initiative that aims to catalyse the next phase of HIV treatment scale up through promoting innovation and efficiency gains. It will help countries to reach and sustain universal access to treatment, and capitalize on the preventive benefit of antiretroviral therapy through focused work in five priority areas: 1) optimize drug regimens; provide point of care diagnosis; 3) reduce costs; 4) adapt delivery systems and 5) mobilize communities.
These priority areas are interrelated and WHO/UNAIDS are working with global partners, technical experts and other UN co-sponsors to implement this initiative in countries, with short-, medium- and long -term targets and milestones.
Latest updates
-
June 2012
-
Use of tenofovir in HIV-infected children and adolescents: A public health perspective
Technical update on treatment optimization
-
Use of tenofovir in HIV-infected children and adolescents: A public health perspective
-
June 2012
-
Pharmacological equivalence and clinical interchangeability of lamivudine and emtricitabine: a review of current literature
Technical update on treatment optimization
-
Pharmacological equivalence and clinical interchangeability of lamivudine and emtricitabine: a review of current literature
-
June 2012
-
Use of efavirenz during pregnancy: A public health perspective
Technical update on treatment optimization
-
Use of efavirenz during pregnancy: A public health perspective
Guidelines and technical documents
- The strategic use of antiretrovirals to help end the HIV epidemic
- The treatment 2.0 framework for action: catalysing the next phase of treatment, care and support
- Towards an improved investment approach for an effective response to HIV/AIDS
- Adapting WHO normative HIV guidelines for national programmes
- DOHA+10: TRIPS flexibilities and access to antiretroviral therapy - lessons from the past, opportunities for the future
- Publications on Treatment 2.0
Meetings
-
WHO informal consultation on medium- and long-term priorities for ARV drug optimization
29-31 May 2012, Montreux, Switzerland -
Developing dosing guidance for new and upcoming formulations of paediatric ARVs in line with Treatment 2.0 priorities
25-26 October 2011, Switzerland - More meetings on Treatment 2.0
Related topics and links
- AIDS medicines and diagnostics service
- Antiretroviral therapy
- Antiretroviral therapy for prevention
- HIV drug resistance
- Integrated management of adolescent and adult illness
- International Treatment Preparedness Coalition
- Treatment 2.0: A community based response
- Treatment of children living with HIV
- Tuberculosis and HIV
- Universal access to HIV/AIDS prevention, treatment and care